Cited by

• Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy.

  Li G, Zhang Z, Reszka-Blanco N, Li F, Chi L, Ma J, Jeffrey J, Cheng L, Su L. Li G, et al. J Virol. 2019 May 29;93(12):e00233-19. doi: 10.1128/JVI.00233-19. Print 2019 Jun 15. J Virol. 2019. PMID: 30971469 Free PMC article.
• Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy.

  Nies-Kraske E, Schacker TW, Condoluci D, Orenstein J, Brenchley J, Fox C, Daucher M, Dewar R, Urban E, Hill B, Guenaga J, Hoover S, Maldarelli F, Hallahan CW, Horn J, Kottilil S, Chun TW, Folino M, Palmer S, Wiegand A, O'Shea MA, Metcalf JA, Douek DC, Coffin J, Haase A, Fauci AS, Dybul M. Nies-Kraske E, et al. J Infect Dis. 2009 Jun 1;199(11):1648-56. doi: 10.1086/598980. J Infect Dis. 2009. PMID: 19432547 Free PMC article.
• Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.

  Sedaghat AR, Siliciano RF, Wilke CO. Sedaghat AR, et al. BMC Infect Dis. 2008 Jan 2;8:2. doi: 10.1186/1471-2334-8-2. BMC Infect Dis. 2008. PMID: 18171475 Free PMC article.
• Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial.

  Payne H, Chan MK, Watters SA, Otwombe K, Hsiao NY, Babiker A, Violari A, Cotton MF, Gibb DM, Klein NJ. Payne H, et al. AIDS Res Ther. 2021 Sep 29;18(1):63. doi: 10.1186/s12981-021-00389-1. AIDS Res Ther. 2021. PMID: 34587974 Free PMC article.
• The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.

  Scholz EMB, Kashuba ADM. Scholz EMB, et al. Clin Pharmacol Ther. 2021 Apr;109(4):918-927. doi: 10.1002/cpt.2186. Epub 2021 Feb 28. Clin Pharmacol Ther. 2021. PMID: 33529355 Free PMC article. Review.